InterestPin.com - Board

Follow

Nabil Lally

Nabil_Lally

Nabil Lally's real-time study design model uses live clinical data to accelerate drug development, enabling faster, smarter decisions and reducing time to market for new therapies.

Login
Login

0 repins 0 comments 0 likes

Nabil Lally accelerates drug development by uniting science and strategy, driving faster, smarter paths from molecule to market with Translational Pharmaceutics. linkedin.com/in/nabillally

Login
Login

0 repins 0 comments 0 likes

At DCAT Week 2025 in New York City, Nabil Lally, Senior Director of Business Development at Quotient Sciences, shared key insights on how real-time clinical data can bring speed and certainty to formulation development. https://www.linkedin.com/posts/activity-7327478164534829056-Tziz?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAFxRyuwBtBc0wNq51yxqb8rexGhXexT21pY

Login
Login

0 repins 0 comments 0 likes

As the Senior Director of Business Development at Quotient Sciences, Nabil Lally plays a vital role in aligning scientific innovation with sponsor needs. At ASCPT 2025, his presence symbolized the company's proactive engagement with the clinical pharmacology community. https://www.linkedin.com/posts/quotient-sciences_ascpt-quotientsciences-clinicalpharmacology-activity-7331665313580658691-RJz11

Login
Login

0 repins 0 comments 0 likes

As the Senior Director of Business Development at Quotient Sciences, Nabil Lally plays a vital role in aligning scientific innovation with sponsor needs. At ASCPT 2025, his presence symbolized the company's proactive engagement with the clinical pharmacology community. https://nabillally.blogspot.com/2025/06/nabil-lally-represent-quotient-sciences.html

Login
Login

0 repins 0 comments 0 likes

Back to Top